NCT05379478View on ClinicalTrials.gov

Immune Responses to COVID-19 Infection or Vaccination

CompletedOBSERVATIONAL
Enrollment

403

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

December 1, 2023

Study Completion Date

December 1, 2023

Conditions
COVID-19
Interventions
DIAGNOSTIC_TEST

Laboratory assessment of antibody profiles

Antibody profiles will be determined on submitted plasma samples

Trial Locations (1)

23219

Aditxt, Richmond

All Listed Sponsors
lead

Aditxt, Inc.

INDUSTRY

NCT05379478 - Immune Responses to COVID-19 Infection or Vaccination | Biotech Hunter | Biotech Hunter